Login

Barret Esophagus Screening - Dr Kornpong Vantanasiri, Mayo Clinic 00:00:00

Share On Facebook Share On Twitter

Dr Kornpong Vantanasiri on Barret Esophagus Screening

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Navigating Volatility: Insights on Asset Market Dynamics Amid Rising Geopolitical Tensions | Darius Dale – Founder, 42 Macro
00:10:00
Jerry Shelton & Mark Sawicki of Cryoport: Keynote at Advanced Therapies Congress 2019 | Jerry Shelton - CEO of Cryoport, Inc.
00:10:00
Methodology & Procedure Amper Technologies | Akshat Thirani, CEO, Amper SAAPR:MUN
00:10:00
Silver One Resources: Uncovering Untapped Potential in Nevada and Mexico
00:00:00
Ulrich von Andrian Mallinckrodt Professor of Immunopathology at Harvard Medical School| Understanding Immune Cell Migration
00:10:00
Guiding Principles for Sustainable Leadership | Lard Friese, CEO , Aegon N.V.
00:10:00
Keeping An Eye Out For Exit|Piyush Kharbanda,General Partner,Vertex Ventures
00:10:00
Global Economic Landscapes: BBVA Asset Management's Strategic Outlook for 2023
00:10:00
CEO's Call to Confront Injustice and Lead with Purpose | Michael Hankin, CEO , Brown Advisory LLC.
00:10:00
Canada Silver Cobalt Works: High-Grade Silver and Cobalt Exploration in Ontario
00:10:00
An interview featuring Wil Ralston, CEO of SinglePoint, Inc., provides insights into the company's operations and strategies.
00:10:00
Global venture capital firm focused on multi stage, sector-focused investments|Jenny Lee,Managing Partner,GGV Capital

© 2017 - Neuhu+